A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
The clinic is currently conducting research into single-fraction treatment, where therapy is delivered in one session (while traditional radiotherapy requires 20–40 treatment sessions)
Dr. Debra Barker, Chief Medical Officer, Centauri Therapeutics, said: “This designation from the FDA will be invaluable as we continue to advance toward first in-human trials for CTX-187. The recognition of the potential value of our technology further underpins our belief in its potential to transform treatment paradigms for Gram-negative bacterial infections, filling an urgently needed gap in the market for new and effective treatment options for clinically vulnerable patients.”
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’
Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026
These awards are given to the top-performing Medline distribution centers in the United States across its four tiers of size, as determined by the sales volume distributed out of each facility
“We are dedicated to partnering with our customers on their digital journeys to help elevate care delivery,” said Scott Sagehorn, VP/GM of Smart Care at Stryker. “The SmartHospital Platform is designed to evolve alongside health systems so teams can work more efficiently and stay focused on patient-centered care.”